Ashford Capital Management Inc has filed its 13F form on August 18, 2025 for Q2 2025 where it was disclosed a total value porftolio of $709 Million distributed in 102 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ligand Pharmaceuticals Inc with a value of $34.4M, Stone X Group Inc. with a value of $32.9M, Axon Enterprise, Inc. with a value of $31M, Healthequity, Inc. with a value of $29.3M, and Red Violet, Inc. with a value of $29.2M.

Examining the 13F form we can see an increase of $53.4M in the current position value, from $656M to 709M.

Ashford Capital Management Inc is based out at Wilmington, DE

Below you can find more details about Ashford Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $709 Million
Technology: $212 Million
Healthcare: $122 Million
Financial Services: $84.5 Million
ETFs: $79.4 Million
Industrials: $64.8 Million
Consumer Cyclical: $49.9 Million
Real Estate: $49.7 Million
Basic Materials: $24.4 Million
Other: $22.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 102
  • Current Value $709 Million
  • Prior Value $656 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 18, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 9 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 47 stocks
Track This Portfolio

Track Ashford Capital Management Inc Portfolio

Follow Ashford Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.